C07C 233 - Carboxylic acid amides

Patents for C07C 233 - Carboxylic acid amides (28,881)
11/2002
11/13/2002	EP1256568A1 Intermediates for the preparation of enantiomerically pure cyclopentane and cyclopentene beta amino acids
11/13/2002	EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002	EP0920413B1 Boronic compound complexing reagents and complexes
11/13/2002	EP0811603B1 Aminotetralone derivatives and process for producing the same
11/13/2002	CN1379755A Substituted 2-dialkylamino alkylbiphenyl derivatives
11/13/2002	CN1094122C Method for concentration of aqueous acrylamide solution
11/12/2002	US6479710 Method of catalyzing a gas phase reaction using an acid-base catalyst composed of vanadium pentoxide hydrate
11/12/2002	US6479678 Metal alkoxide taxane and β-lactam compounds
11/12/2002	US6479587 Crosslinkable polyurea polymers
11/12/2002	US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002	US6479548 Substituted stilbenes as glucose uptake enhancers
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/12/2002	CA2090920C Opacifier for water-based compositions
11/12/2002	CA2034983C Dispersant compositions
11/07/2002	WO2002088285A1 Additive composition for a metalworking fluid
11/07/2002	WO2002079137A8 Interleukin-1 and tumor necrosis factor-alpha modulators and their enantiomers, their synthesis and use
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2001036365A3 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
11/07/2002	US20020165413 Made by reacting a 2-oxo-1-cycloalkylcarboxyester with a halogenating agent, and then reacting with ammonia or a primary amine; intermediate to 4,5-tri-or tetramethylene 4-isothiazolin-3-one microbiocides
11/07/2002	US20020165398 Amino-thiophene-amido derivatives
11/07/2002	US20020165282 PPAR agonists
11/07/2002	US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002	US20020165264 Aminal diones as potassium channel openers
11/07/2002	US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/06/2002	EP1254893A2 2-halo-1-cycloalkenecarboxamides and their preparation
11/06/2002	EP1254885A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups
11/06/2002	EP1254145A1 N,o-amidomalonate platinum complexes
11/06/2002	EP1254106A1 Calcilytic compounds
11/06/2002	EP1062310A4 Improved alkanolamides
11/06/2002	EP0788473B1 Novel high enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-beta-amino acids
11/06/2002	CN1378528A Use of carbonylamino derivatives against CNS disorders
11/06/2002	CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002	CN1378481A Stable highly active supported copper based catalysts
11/06/2002	CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/05/2002	WO2001085673A1 Phenyl-substituted 2-enamino-keto nitriles
11/05/2002	US6476246 Unsymmetrical bicycloaliphatic chiral diphosphines and phosphine phosphinites, complexes of these compounds with metals of groups viib, viiib and ib as hydrogenation catalysts
11/05/2002	US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476056 Antiinflammatory agents, psychological disorders
11/05/2002	CA2408209A1 Phenyl-substituted 2-enamino-keto nitriles
11/05/2002	CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
10/2002
10/31/2002	WO2002085877A2 Processes and intermediates for preparing benzyl substituted epoxides
10/31/2002	WO2002085849A2 Process to prepare oxazolidinones
10/31/2002	WO2002085840A1 Process for producing n-formylamino acid and utilization thereof
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002048072A3 Organic reactions with co generating materials
10/31/2002	WO2002036261A3 Catalyst comprising a chiral cationic metal-ligand complex immobilised on a mesoporous alumino-silicate support, its preparation and use in asymmetric hydrogenation
10/31/2002	US20020161266 Performing a one-pot organic reaction, which includes carbon monoxide (CO) as reactant and does not use of an external gas source, by contacting a non-catalyzing CO releasing compound such as a metal carbonyl with an energy source
10/31/2002	US20020161238 Novel methods for the preparation of taxanes using oxazolidine intermediates
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161053 Inflammatory cytokine production inhibitors, matrix metalloprotease production inhibitors, inflammatory cell adhesion molecules incidence inhibitors, antiinflammatory agents
10/31/2002	US20020161050 Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/31/2002	US20020161041 Resorcinol derivatives
10/31/2002	US20020161007 Non-steroidal modulators of estrogen receptors
10/31/2002	CA2445163A1 Processes and intermediates for preparing benzyl substituted epoxides
10/31/2002	CA2444579A1 Process for producing n-formylamino acid and utilization thereof
10/31/2002	CA2440600A1 Process to prepare oxazolidinones
10/30/2002	EP1253139A2 Multioligoanilinated fullerenes
10/30/2002	EP1253128A1 Perfluoroisopropylbenzene derivatives
10/30/2002	EP1252133A2 Pharmaceutical compounds
10/30/2002	EP1251738A1 Novel diphenylethylene compounds
10/30/2002	EP1105359B1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
10/30/2002	EP1004573B1 Aryloxyaniline derivatives
10/30/2002	CN1377337A Process for phenylacetic acid derivatives
10/30/2002	CN1377336A Carboxylic acid derivatives and drugs containing the same
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1377263A Neuropathy improves containing nitrogenous compounds as the active ingredient
10/30/2002	CN1376667A Medical compound with antalgic, inflammation relieving and thrombocyte decoagulating actions
10/30/2002	CN1376664A Propynyl or diene diaryl compounds
10/29/2002	US6472563 Recrystallization from aqueous isopropyl alcohol; high purity; thermodynamically stable
10/29/2002	US6472561 Stable highly active supported copper based catalysts
10/29/2002	US6472528 Synthesis of substituted pyrazolopyrimidines
10/29/2002	US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002	CA2071979C Process for the preparation of cis-beta-phenylglycidic-(2r,3r)acid
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	WO2002083120A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/24/2002	WO2002083090A2 Novel coupling components for oxidative hair colouring
10/24/2002	US20020156295 Coordination catalyst containing ligand
10/24/2002	US20020156061 Administering to a mammal a matrix metalloproteinase inhibiting amount of derivatives of isophthalic acid, isophthalic acid ester or isothalamide compounds to treat cancer, rheumatic arthritis atherosclerosis and osteoporosis
10/24/2002	US20020156054 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002	US20020156049 Highly packed polycationic ammonium, sulfonium and phosphonium lipids
10/24/2002	US20020155993 Especially those derived from two alpha-amino acids independently selected from the group consisting of glutamic acid, aspartic acid, tyrosine, phenylalanine, and optical isomers thereof.
10/24/2002	US20020155607 Multifunctional molecular complexes for gene transfer to cells
10/24/2002	DE10118883A1 Oxidation dye composition for dyeing keratinic fibers, especially human hair, includes an N-fluoroalkyl or N-hydroxyalkyl 2,6-dialkyl-3-aminophenol derivative as a coupler
10/24/2002	CA2763637A1 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	EP1251127A1 Novel sidechain-bearing taxanes and intermediates thereof
10/23/2002	EP1250302A1 Method for producing carboxylic acids by alcohol oxidation
10/23/2002	EP1105449A4 Amphoteric derivatives of aliphatic polyamines with fatty acids, esters or triglycerides
10/23/2002	CN1376143A Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
10/23/2002	CA2381875A1 Multioligoanilinated fullerenes
10/22/2002	US6469210 Excellent fungicidal activity
10/22/2002	US6469199 Secondary aspartic acid amide esters
10/22/2002	US6469148 Of high isomeric purity, includes reacting a benzaldehyde, zinc chloride solution with galactose, filtering, diluting filtrate with organic solvent, extracting with cold water and ion exchanging to remove zinc ions
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
10/22/2002	US6468487 Nitration or carboxylation catalysts

1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 289